Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
Like many tech stocks, Alphabet's (NASDAQ: GOOGL) (NASDAQ: GOOG) stock pulled back in recent months. Investors still question ...
Alphabet's AI integration, robust cash flow, and profitable Google Cloud make it a top investment choice. See more on GOOG ...
Isomorphic Labs, the Alphabet Inc.-owned company that uses artificial intelligence to discover drugs, has raised $600 million ...
Alphabet’s Gemini 2.5 Pro sets new AI benchmarks, powered by DeepMind and custom TPUs. Learn why GOOG stock offers long-term ...
Explore more
Tech biggie Alphabet’s Google is set to rent chipmaker Nvidia servers from the recently listed CoreWeave . The news was first reported by The Information, citing people familiar ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...
While two AI leaders with undeniable competitive moats are historically cheap, another Wall Street darling is staring down a ...
We recently published a list of 10 AI Stocks Dominating the News This Week. In this article, we are going to take a look at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results